Characterization of the carrier-mediated transport of levofloxacin, a fluoroquinolone antimicrobial agent, in rabbit cornea

被引:28
作者
Kawazu, K [1 ]
Midori, Y [1 ]
Shiono, H [1 ]
Ota, A [1 ]
机构
[1] Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ophthalm Res Div, Ikoma 6300101, Japan
关键词
D O I
10.1211/0022357991773168
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cornea presents a formidable barrier to drug penetration. The fluoroquinolone levofloxacin, which is an effective antimicrobial agent, has the potential to be used in the topical treatment of ocular disease. Thus, we sought to characterize how levofloxacin penetrates the cornea. To perform this characterization, we measured the time dependent permeation of levofloxacin across the isolated rabbit cornea using a diffusion chamber, and compared it with antipyrine fluxes. Levofloxacin permeation into the receiver epithelial-side bathing solution (pH = 6.5) from the donor endothelial-side (pH = 7.4) reached 3.00 nmol cm(-2) cornea after 2 h, whereas in the opposite direction permeation was 1.89 nmol cm(-2) cornea. Based on the temperature-dependent effects on permeation, the calculated energy of activation for permeation, E-a, was 31.3 kcal mol(-1) whereas E-a for antipyrine, a marker of diffusion, was 11.0 kcal mol(-1). The transport of levofloxacin from epithelium to endothelium was concentration-dependent and had both a linear and saturable component. Evaluation of the kinetic parameters, J(max), apparent K-m and k(d) showed that they were 38.78 pmol min(-1) cm(-2), 3.83 mM and 0.0135 mu L min(-1) cm(-2) respectively. These results, coupled with the fact that levofloxacin permeation reached a maximum value at pH 6.5, suggest that levofloxacin transport across the cornea is carrier mediated. However, at present, it cannot be ascertained whether such a system is localized in either the corneal epithelial or the endothelial layer.
引用
收藏
页码:797 / 801
页数:5
相关论文
共 18 条
[1]  
FUKUDA M, 1995, J JPN OPHTHALMOL SOC, V99, P532
[2]   MECHANISMS OF CORNEAL DRUG PENETRATION .1. INVIVO AND INVITRO KINETICS [J].
GRASS, GM ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) :3-14
[3]   ACTIVE SECRETION OF THE FLUOROQUINOLONE CIPROFLOXACIN BY HUMAN INTESTINAL EPITHELIAL CACO-2 CELL-LAYERS [J].
GRIFFITHS, NM ;
HIRST, BH ;
SIMMONS, NL .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) :575-576
[4]  
GRIFFITHS NM, 1994, J PHARMACOL EXP THER, V269, P496
[5]   SYNTHESIS AND ANTIBACTERIAL ACTIVITIES OF OPTICALLY-ACTIVE OFLOXACIN [J].
HAYAKAWA, I ;
ATARASHI, S ;
YOKOHAMA, S ;
IMAMURA, M ;
SAKANO, KI ;
FURUKAWA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) :163-164
[6]   THE INTESTINAL TRANSPORT MECHANISM OF FLUOROQUINOLONES - INHIBITORY EFFECT OF CIPROFLOXACIN, AN ENOXACIN DERIVATIVE, ON THE MEMBRANE POTENTIAL-DEPENDENT UPTAKE OF ENOXACIN [J].
HIRANO, T ;
ISEKI, K ;
SATO, I ;
MIYAZAKI, S ;
TAKADA, M ;
KOBAYASHI, M ;
SUGAWARA, M ;
MIYAZAKI, K .
PHARMACEUTICAL RESEARCH, 1995, 12 (09) :1299-1303
[7]  
HIRANO T, 1995, BIOL PHARM BULL, V18, P342
[8]  
Kawashima Y, 1995, ATARASHII GANKA, V12, P791
[9]  
KAWAZU K, 1996, ATARASHII GANKA, V13, P259
[10]  
Ohtomo T, 1996, J PHARMACOL EXP THER, V276, P1143